Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy. Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society

Neurology

Volumn 62, Issue 8, 2004, Pages 1252-1260

  French, J A ^a   Kanner, A M ^b   Bautista, J ^c   Abou Khalil, B ^d   Browne, T ^e   Harden, C L ^f   Theodore, W H ^g   Bazil, C ^h   Stern, J ⁱ   Schachter, S C ⁱ   Bergen, D ^b   Hirtz, D ^g   Montouris, G D ^e   Nespeca, M ^j   Gidal, B ^k   Marks Jr , W J ^l   Turk, W R ^m   Fischer, J H ⁿ   Bourgeois, B ^o   Wilner, A ^p   Faught Jr , R E ^q   Sachdeo, R C ^r   Beydoun, A ^s   Glauser, T A ^t   more..

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

^g NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^h New York Presbyterian Hospital Columbia University Medical Center   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j RADY CHILDREN'S HOSPITAL   (United States)

^k University of Wisconsin Health   (United States)

^l Univ CA S Francisco Epilepsy Ctr   (United States)

^m NEMOURS CHILDREN S CLINIC   (United States)

ⁿ UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^o BOSTON CHILDREN S HOSPITAL   (United States)

^p Univ of Alabama School of Medicine ^*

^q UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^r UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^s UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^t CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; ERYTHROMYCIN; ETHOSUXIMIDE; ETIRACETAM; GABAPENTIN; HALOPERIDOL; LAMOTRIGINE; ORAL CONTRACEPTIVE AGENT; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VERAPAMIL; VITAMIN D; WARFARIN; ZONISAMIDE;

ABDOMINAL PAIN; ANHIDROSIS; ANOREXIA; ARTHRITIS; BEHAVIOR DISORDER; CLINICAL TRIAL; DISSEMINATED INTRAVASCULAR CLOTTING; DIZZINESS; DRUG EFFICACY; DRUG TOLERABILITY; EPILEPSY; EPILEPTIC DISCHARGE; FATIGUE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HEADACHE; HUMAN; HYPERSENSITIVITY REACTION; HYPONATREMIA; INSOMNIA; IRRITABILITY; KIDNEY FAILURE; LANGUAGE DISABILITY; LIVER FAILURE; METABOLIC ACIDOSIS; MUSCLE WEAKNESS; NEPHROLITHIASIS; OPEN ANGLE GLAUCOMA; PERIPHERAL EDEMA; PHOTOSENSITIVITY; PRIORITY JOURNAL; RASH; REVIEW; SIDE EFFECT; SOMNOLENCE; SPIKE WAVE; STEVENS JOHNSON SYNDROME; STUPOR; TIC; TOXIC EPIDERMAL NECROLYSIS; WEIGHT REDUCTION;

EID: 11144356543     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000123693.82339.FC     Document Type: Review

References (21)

1. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1993;34:453-468.
2. Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia 1991;32:429-445.
3. Practice parameter: management issues for women with epilepsy (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1998;51:944-948.
4. Patsalos PN, Froscher W, Pisani F, van Rijn CM. The importance of drug interactions in epilepsy therapy. Epilepsia 2002;43:365-385.
5. Isojarvi I, Rattya J, Myllyla V, et al. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Ann Neurol 1998;43:446-451.
6. Morrell MJ, Giudice L, Flynn KL, et al. Predictors of ovulatory failure in women with epilepsy. Ann Neurol 2002;52:704-711.
7. Kwan P, Brodie MJ. Effectiveness of first antiepileptic drug. Epilepsia 2001;42:1255-1260.
8. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342:314-319.
9. Chadwick DW, Anhut H, Greiner MJ, et al. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77. Neurology 1998;51:1282-1288.
10. Brodie MJ, Overstall PW, Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. Epilepsy Res 1999;37:81-87.
11. Brodie MJ, Richens A, Yuen AW. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Lancet 1995;345:476-479.
12. Steiner TJ, Dellaportas CL, Findley LJ, et al. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin. Epilepsia 1999;40:601-607.
13. Gilliam FG, Veloso F, Bomhof MAM, et al., and the Topiramate EPMN 104 Study Group. A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy. Neurology 2003;60:196-201.
14. Privitera MD, Brodie MJ, Mattson RH, Chadwick DW, Neto W, Wang S. Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol Scand 2003;107:165-175.
15. Bill PA, Vigonius U, Pohlmann H, et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy. Epilepsy Res 1997;27:195-204.
16. Christe W, Kramer G, Vigonius U, et al. A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy. Epilepsy Res 1997;26:451-460.
17. Dam M, Ekberg R, Loyning Y, et al. A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy. Epilepsy Res 1989;3:70-76.
18. Guerreiro MM, Vigonius U, Pohlmann H, et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Res 1997;27:205-213.
19. Frank LM, Enlow T, Holmes GL, et al. Lamictal (lamotrigine) monotherapy for typical absence seizure in children. Epilepsia 1999;40:973-979.
20. Trudeau V, Myers S, LaMoreaux L, et al. Gabapentin in naive childhood absence epilepsy: results from two double-blind, placebo-controlled, multicenter studies. J Child Neurol 1996;11:470-475.
21. Karlawish JHT, French J. Issues in drug study design: the ethical and scientific shortcomings of current monotherapy epilepsy trials in newly diagnosed patients. Epilepsy Behavior 2001;2:193-200.